Prophase Labs Inc PRPH.OQ reported a quarterly adjusted loss of $1.59 per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -51 cents. The lone analyst forecast for the quarter was for a loss of 24 cents per share.
Revenue rose 157.1% to $-2.48 million from a year ago; analysts expected $3.77 million.
Prophase Labs Inc's reported EPS for the quarter was a loss of $1.59.
Prophase Labs Inc shares had held steady so far this quarter and lost 46.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 366.7% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
Wall Street's median 12-month price target for Prophase Labs Inc is $18.50
This summary was machine generated from LSEG data April 1 at 11:25 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | -0.24 | -1.59 | Missed |
Sep. 30 2024 | 0.04 | -0.35 | Missed |
Jun. 30 2024 | -0.24 | -0.33 | Missed |
Mar. 31 2024 | -0.28 | -0.07 | Beat |
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。